LAVA Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.592; its P/E ratio is -1.78; LAVA Therapeutics is scheduled to report earnings on May 15, 2024, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	-	-	$ 15.26M	$ 468.00K	$ 1.00M
Gross Profit	-	-	-	-	-
EBIT	-	-	$ -1.51M	$ -7.75M	$ -10.33M
EBITDA	-	-	$ -1.34M	$ -7.58M	$ -10.16M
Net Income Common Stockholders	-	-	$ 997.00K	$ -7.92M	$ -10.55M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 95.57M	$ 132.87M	$ 92.72M	$ 110.71M	$ 124.16M
Total Assets	$ 101.71M	$ 143.43M	$ 149.89M	$ 115.31M	$ 129.51M
Total Debt	$ 6.31M	$ 5.45M	$ 4.63M	$ 4.83M	$ 5.10M
Net Debt	$ -89.26M	$ -127.42M	$ -88.09M	$ -105.88M	$ -119.06M
Total Liabilities	$ 50.53M	$ 57.38M	$ 57.23M	$ 21.27M	$ 21.10M
Stockholders Equity	$ 51.18M	$ 86.32M	$ 92.66M	$ 94.04M	$ 108.41M
Cash Flow	-
Free Cash Flow	-	-	$ -14.32M	$ -9.74M	$ -7.95M
Operating Cash Flow	-	-	$ -14.34M	$ -9.72M	$ -7.63M
Investing Cash Flow	-	-	$ 6.58M	$ 3.53M	$ 3.37M
Financing Cash Flow	-	-	$ -7.00K	$ 36.00K	$ 270.00K

Currency in USD

LAVA Therapeutics Earnings and Revenue History

Income Statement >

LAVA Therapeutics Debt to Assets

Balance Sheet >

LAVA Therapeutics Cash Flow

Cash Flow >

LAVA Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing